|
WO1998004569A1
(en)
*
|
1996-07-26 |
1998-02-05 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
ES2187991T3
(es)
*
|
1997-07-25 |
2003-06-16 |
Gilead Sciences Inc |
Composiciones de analogo de nucleotido.
|
|
PT1243590E
(pt)
*
|
1997-07-25 |
2005-05-31 |
Gilead Sciences Inc |
Composicao de analogos nuclotidicos e metodo de sintese
|
|
DK1243590T3
(da)
*
|
1997-07-25 |
2005-07-25 |
Gilead Sciences Inc |
Nukleotid-analog sammensætning og syntesemetode
|
|
US6194391B1
(en)
*
|
1998-06-24 |
2001-02-27 |
Emory University |
3′-azido-2′,3′-dideoxyuridine administration to treat HIV and related test protocol
|
|
HRP20030047B1
(hr)
*
|
2000-07-21 |
2016-02-26 |
Gilead Sciences, Inc. |
Prolijekovi koji su fosfonatni analozi nukleotida i metode njihovog odabira te njihova priprava
|
|
TW200408645A
(en)
|
2002-04-26 |
2004-06-01 |
Gilead Sciences Inc |
Non nucleoside reverse transcriptase inhibitors
|
|
PT1583542E
(pt)
|
2003-01-14 |
2008-09-17 |
Gilead Sciences Inc |
Composições e métodos para terapia de combinação antiviral
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
CN101410120A
(zh)
*
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
|
SG182849A1
(en)
|
2003-04-25 |
2012-08-30 |
Gilead Sciences Inc |
Antiviral phosphonate analogs
|
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
US7427636B2
(en)
|
2003-04-25 |
2008-09-23 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
EP1620109A2
(en)
|
2003-04-25 |
2006-02-01 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
WO2004096285A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-infective phosphonate conjugates
|
|
NZ543864A
(en)
|
2003-06-16 |
2009-10-30 |
Leuven K U Res & Dev |
Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
|
|
US7432273B2
(en)
|
2003-10-24 |
2008-10-07 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
WO2005044279A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Purine nucleoside phosphonate conjugates
|
|
WO2005042773A1
(en)
|
2003-10-24 |
2005-05-12 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds
|
|
BRPI0417988A
(pt)
|
2003-12-22 |
2007-04-27 |
Gilead Sciences Inc |
análogos de fosfonato antivirais
|
|
MXPA06007095A
(es)
*
|
2003-12-22 |
2006-09-04 |
Gilead Sciences Inc |
Conjugados de fosfonato inhibidores de cinasa.
|
|
PT2258376T
(pt)
|
2004-07-27 |
2019-05-31 |
Gilead Sciences Inc |
Análogos fosfonatados de compostos inibidores do vih
|
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
|
WO2006133632A1
(fr)
*
|
2005-06-13 |
2006-12-21 |
Brightgene Bio-Medical Technology Co., Ltd. |
Promedicament analogue nucleotidique et sa preparation
|
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
|
EP2161023A3
(en)
|
2007-04-13 |
2010-12-29 |
Southern Research Institute |
Anti-angiogenic agents and methods of use.
|
|
EP2160394A1
(en)
*
|
2007-05-22 |
2010-03-10 |
Ultimorphix Technologies B.v. |
Tenofovir disoproxil hemi-fumaric acid co-crystal
|
|
WO2009064174A1
(en)
*
|
2007-11-14 |
2009-05-22 |
Ultimorphix Technologies B.V. |
Polymorphic form of tenofovir disoproxil fumarate, method for its preparation and use
|
|
EP2291386B1
(en)
*
|
2008-04-25 |
2016-01-13 |
Cipla Limited |
Crystalline form of tenofovir disoproxil and a process for its preparation
|
|
BRPI0915878A2
(pt)
|
2008-07-08 |
2015-11-03 |
Gilead Sciences Inc |
sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende
|
|
CN102093422B
(zh)
*
|
2009-12-10 |
2015-02-25 |
中国人民解放军军事医学科学院毒物药物研究所 |
无环核苷膦酸酯衍生物及其医药用途
|
|
US20140073607A1
(en)
*
|
2011-05-10 |
2014-03-13 |
Okapi Sciences Nv |
Compounds for use in the treatment of feline retroviral infections
|
|
AP3639A
(en)
|
2011-08-16 |
2016-03-13 |
Gilead Sciences Inc |
Tenofovir alafenamide hemifumarate
|
|
CN103626802A
(zh)
*
|
2012-08-23 |
2014-03-12 |
重庆药友制药有限责任公司 |
一种制备替诺福韦的新方法
|
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
|
US9227990B2
(en)
|
2012-10-29 |
2016-01-05 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
|
EP2860185A1
(en)
|
2013-10-09 |
2015-04-15 |
Zentiva, k.s. |
An improved process for the preparation of Tenofovir disoproxil and pharmaceutically acceptable salts thereof
|
|
PT2860184T
(pt)
|
2013-10-09 |
2018-11-20 |
Zentiva Ks |
Sal de di-hidrogenofosfato de tenofovir disoproxil
|
|
TWI660965B
(zh)
*
|
2014-01-15 |
2019-06-01 |
美商基利科學股份有限公司 |
泰諾福韋之固體形式
|
|
PT3661937T
(pt)
|
2017-08-01 |
2021-09-24 |
Gilead Sciences Inc |
Formas cristalinas de ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofurano-2-il)oxi)metil)(fenoxi)fosforil)-l-alaninato de etil (gs-9131) para tratamento de infeções virais
|
|
CN107805202A
(zh)
*
|
2017-12-01 |
2018-03-16 |
内蒙古圣氏化学股份有限公司 |
一种氯甲基异丙基碳酸酯连续化反应装置及方法
|